SCHEMBL31269340

SCHEMBL31269340

CC1(Oc2ncnc3c2nc(-c2ccc(OCCC(=O)O)cc2Cl)n3Cc2ccc(Cl)c(Cl)c2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 3/20 0.36
▸ S1PR3 Q99500 1/20 0.36
▸ PIK3CD O00329 1/20 0.35
▸ PTGDR2 Q9Y5Y4 3/20 0.35
▸ CCR2 P41597 2/20 0.35
▸ S1PR5 Q9H228 2/20 0.34
▸ PDGFRA P16234 1/20 0.34
▸ ROCK1 Q13464 1/20 0.34
▸ ABCB11 O95342 2/20 0.34
▸ PLA2G2A P14555 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MMP1 P03956 1/20 0.33
▸ MMP9 P14780 1/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ PIK3C2B O00750 1/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31321937 0.93 PLA2G2A (0.40) PIK3CDPLA2G2A
SCHEMBL31269288 0.91 PLA2G2A (0.36) S1PR1S1PR3PIK3CDPLA2G2AFFAR1
SCHEMBL31269035 0.91 CNR1 (0.36) PIK3CDPTGDR2S1PR5PLA2G2AFFAR1
SCHEMBL31269325 0.89 S1PR1 (0.39) S1PR1PIK3CDPTGDR2S1PR5PDGFRA
SCHEMBL31268849 0.88 PIK3CD (0.37) S1PR1PIK3CDPTGDR2S1PR5PLA2G2A
SCHEMBL30983523 0.87 PLA2G2A (0.38) PIK3CDPTGDR2PLA2G2AFFAR4
SCHEMBL31269149 0.87 CNR1 (0.36) PIK3CDPLA2G2AFFAR4
SCHEMBL31268992 0.87 CNR1 (0.35) PIK3CDPTGDR2S1PR5PLA2G2AFFAR1
SCHEMBL30983451 0.87 PLA2G2A (0.38) PIK3CDPTGDR2PLA2G2A
SCHEMBL31268962 0.87 PIK3CD (0.36) S1PR1PIK3CDS1PR5PLA2G2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback